Group One Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Hold |
0
| – | – | – | 3480 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 3483 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 3396 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 3245 |
|
2021
Q1 | – | Sell |
-193
| Closed | -$27K | – | 3054 |
|
2020
Q4 | $27K | Buy |
+193
| New | +$27K | ﹤0.01% | 1264 |
|
2018
Q3 | – | Sell |
-136
| Closed | -$11K | – | 2196 |
|
2018
Q2 | $11K | Hold |
136
| – | – | ﹤0.01% | 1139 |
|
2018
Q1 | $12K | Buy |
136
+71
| +109% | +$6.27K | ﹤0.01% | 1090 |
|
2017
Q4 | $48K | Buy |
+65
| New | +$48K | ﹤0.01% | 940 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 1987 |
|
2017
Q2 | – | Sell |
-16
| Closed | -$5K | – | 1957 |
|
2017
Q1 | $5K | Sell |
16
-58
| -78% | -$18.1K | ﹤0.01% | 1139 |
|
2016
Q4 | $44K | Buy |
74
+14
| +23% | +$8.32K | ﹤0.01% | 850 |
|
2016
Q3 | $68K | Buy |
60
+13
| +28% | +$14.7K | ﹤0.01% | 708 |
|
2016
Q2 | $51K | Sell |
47
-35
| -43% | -$38K | ﹤0.01% | 722 |
|
2016
Q1 | $105K | Buy |
+82
| New | +$105K | ﹤0.01% | 574 |
|
2015
Q4 | – | Sell |
-151
| Closed | -$167K | – | 1928 |
|
2015
Q3 | $167K | Buy |
151
+86
| +132% | +$95.1K | ﹤0.01% | 633 |
|
2015
Q2 | $65K | Sell |
65
-43
| -40% | -$43K | ﹤0.01% | 866 |
|
2015
Q1 | $110K | Buy |
108
+53
| +96% | +$54K | ﹤0.01% | 666 |
|
2014
Q4 | $184K | Sell |
55
-3
| -5% | -$10K | ﹤0.01% | 551 |
|
2014
Q3 | $168K | Buy |
+58
| New | +$168K | ﹤0.01% | 591 |
|
2014
Q2 | – | Sell |
-59
| Closed | -$322K | – | 2000 |
|
2014
Q1 | $322K | Buy |
+59
| New | +$322K | 0.01% | 435 |
|